A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
Cysteinyl leukotrienes (cysLTs) are member of eicosanoid inflammatory lipid mediators
family produced by oxidation of arachidonic acid by action of the enzyme 5-lipoxygenase (5 …
family produced by oxidation of arachidonic acid by action of the enzyme 5-lipoxygenase (5 …
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.
SO Rahman, RK Singh, S Hussain… - European Journal of …, 2018 - europepmc.org
Cysteinyl leukotrienes (cysLTs) are member of eicosanoid inflammatory lipid mediators
family produced by oxidation of arachidonic acid by action of the enzyme 5-lipoxygenase (5 …
family produced by oxidation of arachidonic acid by action of the enzyme 5-lipoxygenase (5 …
[引用][C] A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
SO Rahman, RK Singh, S Hussain, M Akhtar… - European Journal of …, 2019 - cir.nii.ac.jp
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the
neurological complications associated with Alzheimer's disease | CiNii Research CiNii 国立 …
neurological complications associated with Alzheimer's disease | CiNii Research CiNii 国立 …
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
SO Rahman, RK Singh, S Hussain… - European journal …, 2019 - pubmed.ncbi.nlm.nih.gov
Cysteinyl leukotrienes (cysLTs) are member of eicosanoid inflammatory lipid mediators
family produced by oxidation of arachidonic acid by action of the enzyme 5-lipoxygenase (5 …
family produced by oxidation of arachidonic acid by action of the enzyme 5-lipoxygenase (5 …